In the early stages of AMD, complement proteins will accumulate in drusen and Bruch’s membranes; simultaneously, the levels of C3a, C3Bb, and C5a in the patient’s plasma, aqueous humor, or vitreous fluid increase. This evidence concerns the gene C3 and age-related macular degeneration.